Education History
| Undergraduate |
University of Utah |
BS |
|---|---|---|
| Internship |
University of Utah, ARUP |
Intern |
| Graduate Training |
University of Utah |
MS |
| Doctoral Training |
University of Utah |
PhD |
Selected Publications
Journal Article
- Rower JE, Anderson DJ, Sherwin CM, Reilly CA, Ballard PL, McEvoy CT, Wilkins D (2019). Development and validation of an assay for quantifying budesonide in dried blood spots collected from extremely low gestational age neonates. Journal of pharmaceutical and biomedical analysis, 167, 7-14. (Read full article)
- Linakis MW, Rower JE, Roberts JK, Miller EI, Wilkins DG, Sherwin CM (2017). Population pharmacokinetic model of transdermal nicotine delivered from a matrix-type patch. British journal of clinical pharmacology, 83(12), 2709-2717. (Read full article)
- Pollard SH, Cox KJ, Blackburn BE, Wilkins DG, Carrell DT, Stanford JB, Porucznik C (2019). Male exposure to bisphenol A (BPA) and semen quality in the Home Observation of Periconceptional Exposures (HOPE) cohort. Reproductive toxicology (Elmsford, N.Y.), 90, 82-87. (Read full article)
- Linakis MW, Cook SF, Kumar SS, Liu X, Wilkins DG, Gaedigk R, Gaedigk A, Sherwin CMT, van den Anker J (2018). Polymorphic Expression of UGT1A9 is Associated with Variable Acetaminophen Glucuronidation in Neonates: A Population Pharmacokinetic and Pharmacogenetic Study. Clinical pharmacokinetics, 57(10), 1325-1336. (Read full article)
- Fleckenstein AE, Metzger RR, Wilkins DG, Gibb JW, Hanson G (1997). Rapid and reversible effects of methamphetamine on dopamine transporters. The Journal of pharmacology and experimental therapeutics, 282(2), 834-8. (Read full article)
- Curry SC, Padilla-Jones A, Ruha AM, O'Connor AD, Kang AM, Wilkins DG, Jaeschke H, Wilhelms K, Gerkin RD, Acetaminophen Adduct Study Group (2019). The Relationship Between Circulating Acetaminophen-Protein Adduct Concentrations and Alanine Aminotransferase Activities in Patients With and Without Acetaminophen Overdose and Toxicity. Journal of medical toxicology, 15(3), 143-155. (Read full article)
Other
- Magee CP, German CL, Siripathane YH, Curtis PS, Anderson DJ, Wilkins DG, Hanson GR, Fleckenstein A (2020). 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters. The Journal of pharmacology and experimental therapeutics, 374(2), 273-282. (Read full article)